Conference Series LLC Ltd invites the contributors across the globe to participate in the premier “CRISPR-2018”, to discuss the theme: “CRISPR technology to feed, fuel and heal the world”. The conference will be held in Boston, USA during October 19-20, 2018 wherein prompt keynote presentations, Oral talks, Poster presentations and Exhibitions are included.
“CRISPR” (pronounced “crispr”) stands for Clustered Regularly Interspaced Short Palindromic Repeats, which are the hallmark of a bacterial defense system that forms the basis for CRISPR-Cas9 genome editing technology. In the field of genome engineering, the term “CRISPR” or “CRISPR-Cas9” is often used loosely to refer to the various CRISPR-Cas9 and -CPF1, (and other) systems that can be programmed to target specific stretches of genetic code and to edit DNA at precise locations, as well as for other purposes, such as for new diagnostic tools. With these systems, researchers can permanently modify genes in living cells and organisms and, in the future, may make it possible to correct mutations at precise locations in the human genome in order to treat genetic causes of disease. Other systems are now available, such as CRISPR-Cas13’s, that target RNA provide alternate avenues for use, and with unique characteristics that have been leveraged for sensitive diagnostic tools, such as SHERLOCK.
CRISPR genome editing allows scientists to quickly create cell and animal models, which researchers can use to accelerate research into diseases such as cancer and mental illness. In addition, CRISPR is now being developed as a rapid diagnostic.
Studies using in vitro (laboratory) and animal models of human disease have demonstrated that the technology can be effective in correcting genetic defects. Examples of such diseases include cystic fibrosis, cataracts, and Fanconi anemia, according to a 2016 review article published in the journal Nature Biotechnology. These studies pave the way for therapeutic applications in humans.
CRISPR technology has also been applied in the food and agricultural industries to engineer probiotic cultures and to vaccinate industrial cultures (for yogurt, for example) against viruses. It is also being used in crops to improve yield, drought tolerance and nutritional properties.
One other potential application is to create gene drives. These are genetic systems, which increase the chances of a particular trait passing on from parent to offspring.
However, CRISPR-Cas9 is not without its drawbacks.
The genome-editing efficiencies can vary. According to the 2014 Science article by Doudna and Charpentier, in a study conducted in rice, gene editing occurred in nearly 50 percent of the cells that received the Cas9-RNA complex. Whereas other analyses have shown that depending on the target, editing efficiencies can reach as high as 80 percent or more.
There is also the phenomenon of “off-target effects,” where DNA is cut at sites other than the intended target. This can lead to the introduction of unintended mutations.
International conference of CRISPR-2018 is a Research-scientific knowledge bridge, that aims bring together multi-disciplinary luminaries for Thriving innovation in the Biotechnology. The scientific conferences have been carefully structured so as to share knowledge and thoughts through presentations and exhibitions. CRISPR-2018 event with sessions covers all aspects of biotech-driven technique CRISPR and addresses the key issues currently affecting its researches. Attendees can look forward to hearing about the different strategies taken to improve ongoing research and decipher how to overcome technical limitations in research development. This conference is where pharm, investors and Life Science companies find partners, access innovation, find funding and brainstorm the solutions to further their business needs.
To know more about the conference, download the Scientific Program here.
About the Conference
Biotechnology 2018 welcomes all to attend the 22nd World Congress on Biotechnology covering the Future Advancements in the Biotechnology industry professionals and academic communities worldwide. Biotechnology brings its major share of delegation from the industry and the academia. The Biotechnology Conferences 2018 is a remarkable event in the field of Biotechnology. This covers a wide range of topics related to the advancements in the field of Biotechnology conducted in Bangkok, Thailand in the month of November 19-20, 2018
Biotechnology Congress is pleased to invite Academicians, scientists, researchers, educators, professionals, practitioners, Biotechnologists, Microbiologists, Pharmacists, and students to exchange ideas and be informed about the latest research developments in the field.
Conference series LTD is conducting its 22nd World Congress on Biotechnology at Bangkok, Thailand, from November 19-20, 2018. Biotechnology 2018 will provide health practitioners a study of the key role of Biotechnology in Science and Technology. Biotechnology Congress 2018 is aimed to give an opportunity to the experts in the field of Food and Nutrition to examine most recent progressions and difficulties in the field. The Biotechnology Events 2018 is intended to give a fashionable stage to Biotechnologists, enrolled, and different specialists and understudies employed in the field to consider, trade sees and their encounters before an expansive global meeting of people. The gathering invites Presidents, CEO’s, Delegates and modern officials from Industrial and Academic sectors to take part in the instinctive investigative sessions, B2B gatherings and Board talks.
The conference will be organized with the theme of “Current Research & Innovations in Biotechnology “.
Conference Series Organizes 300+ conferences, 500+workshops and 200+symposiums on Clinical, Medicine, Pharma, cardiology diagnosis workshops, cardiac nursing conferences, cardiac conferences and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 500 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Why to attend??
Encounter the target market with members from across the globe, committed to learn about cardiac imaging techniques. This is the best opportunity to outreach the largest gathering of participants from around the world. Conduct presentations, distribute and update knowledge about the current situation of Biotechnology research technique and receive name recognition at this 2-days event. World-eminent speakers, most recent researches, latest treatment techniques and the advanced updates in Biotechnology are the principal features of this conference.
Our Organization would be privileged to welcome the:
• Directors of Pharma and Biotech Associations
• Heads, Deans and Professors of Biotechnology and related departments
• Scientists and Researchers
• Founders and Employees of the related companies
• Biotech & Pharma Associations and Organizations
• Laboratory members and Students working in the field of Biotechnology.